| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $88.3M | -11.1% |
| Cost of Revenue | $77.1M | +2.1% |
| Gross Profit | $11.2M | -52.8% |
| R&D Expense | $9.0M | -37.8% |
| SG&A Expense | $24.2M | +0.3% |
| Operating Income | -$22.0M | -48.5% |
| Pre-tax Income | -$21.5M | -102.2% |
| Income Tax | $1.7M | +46.2% |
| Net Income | -$21.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $120.3M | +426.7% |
| Accounts Receivable | $26.8M | +4.7% |
| Inventory | $81.7M | -4.0% |
| Current Assets | $246.6M | +55.8% |
| Total Assets | $433.8M | +27.8% |
| Current Liabilities | $90.5M | +22.1% |
| Total Liabilities | $99.1M | +17.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.8M | -5.5% |
| Capital Expenditures | $6.0M | +3.9% |
| Investing Cash Flow | -$6.8M | -53.7% |
| Financing Cash Flow | $107.1M | — |
| Free Cash Flow | -$18.8M | -5.0% |
| -82.9% |
| EPS (Basic) | -$0.49 | -81.5% |
| EPS (Diluted) | -$0.49 | -81.5% |
| Stockholders' Equity |
| $273.3M |
| +41.8% |